利索-全球专利检索

  1. 登录
  2. 注册
发明公开
CN107530357A 包含丙酸氟替卡松和昔萘酸沙美特罗的干粉吸入器 无效 - 驳回

包含丙酸氟替卡松和昔萘酸沙美特罗的干粉吸入器
摘要：
本发明提供了干粉吸入器，包括：包含丙酸氟替卡松、昔萘酸沙美特罗和乳糖载体的干粉药物；其中丙酸氟替卡松的递送剂量每次致动小于100μg；其中所述剂量在接受所述剂量30分钟内在患者中提供超过150mL的基线调整的FEV1。一种治疗患者的方法包括向患者施用具有丙酸氟替卡松、昔萘酸沙美特罗和乳糖载体的干粉药物；其中丙酸氟替卡松的递送剂量每次致动小于100pg；并且其中所述剂量在接受所述剂量30分钟内在患者中提供超过150mL的基线调整的FEV1。
摘要（英）：

This invention provides a dry powder inhaler comprising: a dry powder medicament comprising fluticasone propionate, salmeterol xinafoate and a lactose carrier, wherein the delivered dose of fluticasone propionate per actuation is less than 100 [mu]g; and the dose provides a baseline-adjusted FEV1 in a patient of more than 150 mL within 30 minutes of receiving the dose. A method of treating a patient includes administering to a patient the dry powder medicament comprising the fluticasone propionate, the salmeterol xinafoate and the lactose carrier, wherein the delivered dose of fluticasone propionate per actuation is less than 100 pg; and the dose provides a baseline-adjusted FEV1 in a patient of more than 150 mL within 30 minutes of receiving the dose.

0/0